2. Academic Validation
  3. Novel 1,4-Dihydro-2H-pyrano[3,4‑ c]quinoline Compounds for Treating Bacterial Infections, Tuberculosis, or Leprosy

Novel 1,4-Dihydro-2H-pyrano[3,4‑ c]quinoline Compounds for Treating Bacterial Infections, Tuberculosis, or Leprosy

  • ACS Med Chem Lett. 2025 Oct 30;16(11):2204-2205. doi: 10.1021/acsmedchemlett.5c00637.
Ram W Sabnis 1
Affiliations

Affiliation

  • 1 Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
PMID: 41256978 DOI: 10.1021/acsmedchemlett.5c00637
Abstract

Provided herein are novel 1,4-dihydro-2H-pyrano-[3,4-c]-quinoline compounds, pharmaceutical compositions, use of such compounds in treating Bacterial infections, tuberculosis or leprosy, and processes for preparing such compounds.

Figures
Products